• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将治愈率模型应用于癌症研究中心的乳腺癌数据。

Fitting Cure Rate Model to Breast Cancer Data of Cancer Research Center.

作者信息

Baghestani Ahmad Reza, Zayeri Farid, Akbari Mohammad Esmaeil, Shojaee Leyla, Khadembashi Naghmeh, Shahmirzalou Parviz

机构信息

Researcher, Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran E-mail :

出版信息

Asian Pac J Cancer Prev. 2015;16(17):7923-7. doi: 10.7314/apjcp.2015.16.17.7923.

DOI:10.7314/apjcp.2015.16.17.7923
PMID:26625822
Abstract

BACKGROUND

The Cox PH model is one of the most significant statistical models in studying survival of patients. But, in the case of patients with long-term survival, it may not be the most appropriate. In such cases, a cure rate model seems more suitable. The purpose of this study was to determine clinical factors associated with cure rate of patients with breast cancer.

MATERIALS AND METHODS

In order to find factors affecting cure rate (response), a non-mixed cure rate model with negative binomial distribution for latent variable was used. Variables selected were recurrence cancer, status for HER2, estrogen receptor (ER) and progesterone receptor (PR), size of tumor, grade of cancer, stage of cancer, type of surgery, age at the diagnosis time and number of removed positive lymph nodes. All analyses were performed using PROC MCMC processes in the SAS 9.2 program.

RESULTS

The mean (SD) age of patients was equal to 48.9 (11.1) months. For these patients, 1, 5 and 10-year survival rates were 95, 79 and 50 percent respectively. All of the mentioned variables were effective in cure fraction. Kaplan-Meier curve showed cure model's use competence.

CONCLUSIONS

Unlike other variables, existence of ER and PR positivity will increase probability of cure in patients. In the present study, Weibull distribution was used for the purpose of analysing survival times. Model fitness with other distributions such as log-N and log-logistic and other distributions for latent variable is recommended.

摘要

背景

Cox PH模型是研究患者生存情况的最重要统计模型之一。但是,对于长期生存的患者,它可能不是最合适的。在这种情况下,治愈率模型似乎更合适。本研究的目的是确定与乳腺癌患者治愈率相关的临床因素。

材料与方法

为了找到影响治愈率(反应)的因素,使用了一种具有负二项分布的潜在变量的非混合治愈率模型。选择的变量包括复发性癌症、HER2状态、雌激素受体(ER)和孕激素受体(PR)、肿瘤大小、癌症分级、癌症分期、手术类型、诊断时的年龄以及切除的阳性淋巴结数量。所有分析均使用SAS 9.2程序中的PROC MCMC过程进行。

结果

患者的平均(标准差)年龄为48.9(11.1)岁。对于这些患者,1年、5年和10年生存率分别为95%、79%和50%。所有上述变量在治愈比例方面均有影响。Kaplan-Meier曲线显示了治愈模型的适用性。

结论

与其他变量不同,ER和PR阳性的存在会增加患者治愈的概率。在本研究中,使用威布尔分布来分析生存时间。建议使用其他分布(如对数正态分布和对数逻辑分布)以及其他潜在变量分布来进行模型拟合。

相似文献

1
Fitting Cure Rate Model to Breast Cancer Data of Cancer Research Center.将治愈率模型应用于癌症研究中心的乳腺癌数据。
Asian Pac J Cancer Prev. 2015;16(17):7923-7. doi: 10.7314/apjcp.2015.16.17.7923.
2
Breast Cancer Survival Analysis Based on Immunohistochemistry Subtypes (ER/PR/HER2): a Retrospective Cohort Study.基于免疫组织化学亚型(ER/PR/HER2)的乳腺癌生存分析:一项回顾性队列研究。
Arch Iran Med. 2016 Oct;19(10):680-686.
3
Is conservative surgery a good option for patients with "triple negative" breast cancer?对于“三阴性”乳腺癌患者,保守手术是一个好的选择吗?
Breast. 2012 Jun;21(3):401-5. doi: 10.1016/j.breast.2012.04.005. Epub 2012 May 11.
4
Invasive micropapillary carcinoma of the breast: a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma.乳腺浸润性微乳头状癌:一种不常见且高度侵袭性乳腺癌变体的临床病理研究。
Breast J. 2013 Jul-Aug;19(4):374-81. doi: 10.1111/tbj.12128. Epub 2013 May 29.
5
LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.LEA-135表达:其与淋巴结阳性原发性浸润性乳腺癌患者较低的复发风险及总生存期延长的相关性。
Anticancer Res. 2004 Jul-Aug;24(4):2391-400.
6
Lack of either estrogen or progesterone receptor expression is associated with poor survival outcome among luminal A breast cancer subtype.缺乏雌激素或孕激素受体表达与 luminal A 型乳腺癌亚型的不良生存结局相关。
Ann Surg Oncol. 2013 May;20(5):1505-13. doi: 10.1245/s10434-012-2772-x. Epub 2012 Nov 29.
7
Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.雌激素受体阳性、人表皮生长因子受体2阴性乳腺癌的淋巴结转移灶中孕激素受体表达缺失与他莫昔芬治疗后复发相关。
J Clin Pathol. 2017 Nov;70(11):954-960. doi: 10.1136/jclinpath-2016-204304. Epub 2017 Apr 17.
8
[Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].腹股沟淋巴结转移乳腺癌患者的临床病理特征及预后因素:附17例报告
Zhonghua Zhong Liu Za Zhi. 2013 Mar;35(3):207-11. doi: 10.3760/cma.j.issn.0253-3766.2013.03.010.
9
Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.磷酸化HER2在接受辅助曲妥珠单抗治疗的HER2阳性乳腺癌患者中的预后价值。
Breast Cancer. 2015 May;22(3):292-9. doi: 10.1007/s12282-013-0478-y. Epub 2013 Jun 8.
10
Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.乳腺癌中雌激素受体(ER)、孕激素受体(PR)和人表皮生长因子受体2(HER-2/neu,即C-erb B 2)反应模式与组织学分级、肿瘤大小及淋巴结状态的比较
Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):553-6.

引用本文的文献

1
Mortality Rate and Years of Life Lost Due to Breast and Gynecologic Cancers in Southern Iran 2004-2019: A Population-Based Study.2004 - 2019年伊朗南部乳腺癌和妇科癌症导致的死亡率及寿命损失年数:一项基于人群的研究
Iran J Public Health. 2024 Aug;53(8):1890-1897. doi: 10.18502/ijph.v53i8.16295.
2
Survival Rate and Prognostic Factors among Iranian Breast Cancer Patients.伊朗乳腺癌患者的生存率及预后因素
Iran J Public Health. 2020 Feb;49(2):341-350.
3
Comparison Cure Rate Models by DIC Criteria in Breast Cancer Data.基于DIC标准对乳腺癌数据的治愈率模型进行比较
Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1601-1606. doi: 10.22034/APJCP.2018.19.6.1601.
4
Long-Term Disease-Free Survival of Non-Metastatic Breast Cancer Patients in Iran: A Survival Model with Competing Risks Taking Cure Fraction and Frailty into Account.伊朗非转移性乳腺癌患者的长期无病生存:一种考虑治愈分数和虚弱因素的竞争风险生存模型
Asian Pac J Cancer Prev. 2017 Oct 26;18(10):2825-2832. doi: 10.22034/APJCP.2017.18.10.2825.